Process for producing polypeptide
AssigneeKyowa Hakko Kirin Co., Ltd.
InventorsTatsuya Ogawa, Yoshinobu Konno, Naohisa Akashi, Hiroshi Takasugi, Seiji Sugimoto, Keiichi Yano
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Hakko Kirin Co., Ltd.
InventorsTatsuya Ogawa, Yoshinobu Konno, Naohisa Akashi, Hiroshi Takasugi, Seiji Sugimoto, Keiichi Yano
Estimating the term…
The present invention relates to a process for producing a desired polypeptide using rat cells. Specifically, the present invention relates to a process for producing the polypeptide which comprises culturing rat cells such as YB2/3HL.P2.G11.16Ag.20 (hereinafter referred to as YB2/0), preferably rat cells to which a recombinant DNA comprising DNA encoding a desired polypeptide such as an immunologically functional molecule is introduced, in a medium which does not contain serum (hereinafter referred to as a serum-free medium). Among the desired polypeptides obtained by the process of the present invention, an antibody obtained by using a transformant of YB2/0 has a high antibody-dependent cell-mediated cytotoxic activity (hereinafter sometimes referred to as ADCC activity) and is useful as a pharmaceutical agent.
A process for producing a polypeptide, comprising:
A rat myeloma cell line, or hybrid cell line derived from a rat myeloma cell, adapted to a serum-free medium,
A rat cell line adapted to a serum-free medium, which is 61-33γ(FERM BP-7325).
Dependencies are inferred from the claim text.